T cell vaccinology: Exploring the known unknowns

Vaccine

Volumn 31, Issue 2, 2013, Pages 297-305

  Burchill, Matt A ^a   Tamburini, Beth A ^a   Pennock, Nathan D ^a   White, Jason T ^a   Kurche, Jonathan S ^a   Kedl, Ross M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Adjuvant; CD8+ T cell; T cell memory; Vaccine

Indexed keywords

B7 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; LIVE VACCINE; MESSENGER RNA; PROTEIN BCL XL; STAT1 PROTEIN; STAT4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; VACCINE;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; T-LYMPHOCYTES; VACCINES; VACCINES, SUBUNIT;

EID: 84871393376     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.096     Document Type: Review

References (170)

1. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004, 59(January (1)):1-15.
2. Hobson P., Barnfield C., Barnes A., Klavinskis L.S. Mucosal immunization with DNA vaccines. Methods 2003, 31(November (3)):217-224.
3. Polo J.M., Dubensky T.W. Virus-based vectors for human vaccine applications. Drug Discov Today 2002, 7(July (13)):719-727.
4. Coffman R.L., Sher A., Seder R.A. Vaccine adjuvants: putting innate immunity to work. Immunity 2010, 33(October (4)):492-503.
5. Trumpfheller C., Longhi M.P., Caskey M., Idoyaga J., Bozzacco L., Keler T., et al. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. J Intern Med 2012, 271(February (2)):183-192.
6. Mondino A., Khoruts A., Jenkins M.K. The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U.S.A. 1996, 93(March (6)):2245-2252.
7. Pulendran B., Smith J.L., Jenkins M., Schoenborn M., Maraskovsky E., Maliszewski C.R. Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant. J Exp Med 1998, 188(December (11)):2075-2082.
8. Jenkins M.K. The ups and downs of T cell costimulation. Immunity 1994, 1(September (6)):443-446.
9. Kearney E.R., Pape K.A., Loh D.Y., Jenkins M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994, 1(July (4)):327-339.
10. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54(Pt 1):1-13.
11. Barber G.N., Cytoplasmic DNA innate immune pathways Immunol Rev 2011, 243(September (1)):99-108.
12. McGettrick A.F., O'Neill L.A. Regulators of TLR4 signaling by endotoxins. Subcell Biochem 2010, 53:153-171.
13. Saleh M. The machinery of Nod-like receptors: refining the paths to immunity and cell death. Immunol Rev 2011, 243(September (1)):235-246.
14. Prlic M., Hernandez-Hoyos G., Bevan M.J. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J Exp Med 2006, 203(September (9)):2135-2143.
15. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of energy in T-cell clones. Nature 1992, 356(April (6370)):607-609.
16. Ledbetter J.A., Martin P.J., Spooner C.E., Wofsy D., Tsu T.T., Beatty P.G., et al. Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J Immunol 1985, 135(October (4)):2331-2336.
17. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991, 173(March (3)):721-730.
18. Nunes J.A., Truneh A., Olive D., Cantrell D.A. Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules. J Biol Chem 1996, 271(January (3)):1591-1598.
19. Pages F., Ragueneau M., Klasen S., Battifora M., Couez D., Sweet R., et al. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J Biol Chem 1996, 271(April (16)):9403-9409.
20. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989, 7:445-480.
21. Curtsinger J.M., Lins D.C., Mescher M.F. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 2003, 197(May (9)):1141-1151.
22. Curtsinger J.M., Schmidt C.S., Mondino A., Lins D.C., Kedl R.M., Jenkins M.K., et al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 1999, 162(March (6)):3256-3262.
23. Masopust D., Kaech S.M., Wherry E.J., Ahmed R. The role of programming in memory T-cell development. Curr Opin Immunol 2004, 16(April (2)):217-225.
24. Agarwal P., Raghavan A., Nandiwada S.L., Curtsinger J.M., Bohjanen P.R., Mueller D.L., et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 2009, 183(August (3)):1695-1704.
25. Filatenkov A.A., Jacovetty E.L., Fischer U.B., Curtsinger J.M., Mescher M.F., Ingulli E. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance. J Immunol 2005, 174(June (11)):6909-6917.
26. Keppler S.J., Aichele P. Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. Eur J Immunol 2011, 41(November (11)):3176-3186.
27. Keppler S.J., Theil K., Vucikuja S., Aichele P. Effector T-cell differentiation during viral and bacterial infections: role of direct IL-12 signals for cell fate decision of CD8(+) T cells. Eur J Immunol 2009, 39(July (7)):1774-1783.
28. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005, 202(September (5)):637-650.
29. Mescher M.F., Curtsinger J.M., Agarwal P., Casey K.A., Gerner M., Hammerbeck C.D., et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 2006, June (211):81-92.
30. Pearce E.L., Shen H. Generation of CD8 T cell memory is regulated by IL-12. J Immunol 2007, 179(August (4)):2074-2081.
31. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010, 28:445-489.
32. Kaech S.M., Wherry E.J. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 2007, 27(September (3)):393-405.
33. Cui W., Liu Y., Weinstein J.S., Craft J., Kaech S.M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011, 35(November (5)):792-805.
34. Siegel A.M., Heimall J., Freeman A.F., Hsu A.P., Brittain E., Brenchley J.M., et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011, 35(November (5)):806-818.
35. Li Q., Rao R.R., Araki K., Pollizzi K., Odunsi K., Powell J.D., et al. A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity 2011, 34(April (4)):541-553.
36. Rao R.R., Li Q., Odunsi K., Shrikant P.A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 2010, 32(January (1)):67-78.
37. Watts T.H. Tnf/Tnfr family members in costimulation of T cell responses. Annu Rev Immunol 2005, 23:23-68.
38. Ahonen C.L., Doxsee C.L., McGurran S.M., Riter T.R., Wade W.F., Barth R.J., et al. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J Exp Med 2004, 199(March (6)):775-784.
39. Sanchez P.J., McWilliams J.A., Haluszczak C., Yagita H., Kedl R.M. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J Immunol 2007, 178(February (3)):1564-1572.
40. Sanchez P.J., Kedl R.M. An alternative signal 3: CD8(+) T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling. Vaccine 2011, 30(February (6)):1154-1161.
41. Kurche J.S., Burchill M.A., Sanchez P.J., Haluszczak C., Kedl R.M. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J Immunol 2010, 185(August (4)):2106-2115.
42. DeBenedette M.A., Shahinian A., Mak T.W., Watts T.H. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J Immunol 1997, 158(January (2)):551-559.
43. Shuford W.W., Klussman K., Tritchler D.D., Loo D.T., Chalupny J., Siadak A.W., et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 1997, 186(July (1)):47-55.
44. Takahashi C., Mittler R.S., Vella A.T. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 1999, 162(May (9)):5037-5040.
45. Vaitaitis G.M., Wagner D.H. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. PLoS ONE 2008, 3(4):e2076.
46. van Gisbergen K.P., Klarenbeek P.L., Kragten N.A., Unger P.P., Nieuwenhuis M.B., Wensveen F.M., et al. The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants. Immunity 2011, 35(July (1)):97-108.
47. Steinman R.M., Adams J.C., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice IV. Identification and distribution in mouse spleen. J Exp Med 1975, 141(April (4)):804-820.
48. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice I. Morphology, quantitation, tissue distribution. J Exp Med 1973, 137(May (5)):1142-1162.
49. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice II. Functional properties in vitro. J Exp Med 1974, 139(February (2)):380-397.
50. Steinman R.M. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2011, 30 (April):1-22.
51. Nussenzweig M.C., Steinman R.M., Gutchinov B., Cohn Z.A. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J Exp Med 1980, 152(October (4)):1070-1084.
52. Ballesteros-Tato A., Leon B., Lund F.E., Randall T.D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 2010, 11(March (3)):216-224.
53. den Haan J.M.M., Lehar S.M., Bevan M.J. CD8+ but Not CD8-dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000, 192(December (12)):1685-1696.
54. Desch A.N., Randolph G.J., Murphy K., Gautier E.L., Kedl R.M., Lahoud M.H., et al. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med 2011, 208(August (9)):1789-1797.
55. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315(January (5808)):107-111.
56. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322(November (5904)):1097-1100.
57. Jongbloed S.L., Kassianos A.J., McDonald K.J., Clark G.J., Ju X., Angel C.E., et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010, 207(June (6)):1247-1260.
58. Soares H., Waechter H., Glaichenhaus N., Mougneau E., Yagita H., Mizenina O., et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med 2007, 204(May (5)):1095-1106.
59. Oh J.Z., Kurche J.S., Burchill M.A., Kedl R.M. TLR7 enables cross-presentation by multiple dendritic cell subsets through a Type I IFN-dependent pathway. Blood 2011, 118(September (11)):3028-3038.
60. Allan R.S., Smith C.M., Belz G.T., van Lint A.L., Wakim L.M., Heath W.R., et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003, 301(September (5641)):1925-1928.
61. Allan R.S., Waithman J., Bedoui S., Jones C.M., Villadangos J.A., Zhan Y., et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006, 25(July (1)):153-162.
62. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., Caminschi I., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009, 10(May (5)):488-495.
63. Hao X., Kim T.S., Braciale T.J. Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol 2008, 82(May (10)):4908-4919.
64. Ho A.W., Prabhu N., Betts R.J., Ge M.Q., Dai X., Hutchinson P.E., et al. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J Immunol 2011, 187(December (11)):6011-6021.
65. Kim T.S., Braciale T.J. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE 2009, 4(1):e4204.
66. Smed-Sorensen A., Chalouni C., Chatterjee B., Cohn L., Blattmann P., Nakamura N., et al. Influenza a virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathogens 2011, 8(March (3)):e1002572.
67. Akiba H., Oshima H., Takeda K., Atsuta M., Nakano H., Nakajima A., et al. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol 1999, 162(June (12)):7058-7066.
68. Arens R., Schepers K., Nolte M.A., van Oosterwijk M.F., van Lier R.A., Schumacher T.N., et al. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med 2004, 199(June (11)):1595-1605.
69. Borst J., Hendriks J., Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005, 17(June (3)):275-281.
70. Bullock T.N., Yagita H. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J Immunol 2005, 174(January (2)):710-717.
71. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009, 9(April (4)):271-285.
72. Laouar A., Haridas V., Vargas D., Zhinan X., Chaplin D., van Lier R.A., et al. CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol 2005, 6(July (7)):698-706.
73. McWilliams J.A., Sanchez P.J., Haluszczak C., Gapin L., Kedl R.M. Multiple innate signaling pathways cooperate with CD40 to induce potent CD70-dependent cellular immunity. Vaccine 2010, 28(February (6)):1468-1476.
74. Rowley T.F., Al-Shamkhani A. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. J Immunol 2004, 172(May (10)):6039-6046.
75. Taraban V.Y., Rowley T.F., Al-Shamkhani A. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J Immunol 2004, 173(December (11)):6542-6546.
76. Taraban V.Y., Rowley T.F., Tough D.F., Al-Shamkhani A. Requirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell priming. J Immunol 2006, 177(September (5)):2969-2975.
77. Dong H., Franklin N.A., Roberts D.J., Yagita H., Glennie M.J., Bullock T.N. CD27 stimulation promotes the frequency of IL-7 receptor-expressing memory precursors and prevents IL-12-mediated loss of CD8+ T cell memory in the absence of CD4+ T cell help. J Immunol 2012, 188(April (8)):3829-3838.
78. Penaloza-MacMaster P., Ur Rasheed A., Iyer S.S., Yagita H., Blazar B.R., Ahmed R. Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice. J Virol 2011, 85(July (13)):6168-6174.
79. Beishuizen C.R., Kragten N.A., Boon L., Nolte M.A., van Lier R.A., van Gisbergen K.P. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions. J Immunol 2009, 183(November (10)):6442-6451.
80. Nolte M.A., van Olffen R.W., van Gisbergen K.P., van Lier R.A. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009, 229(May (1)):216-231.
81. Wensveen F.M., Unger P.P., Kragten N.A., Derks I.A., ten Brinke A., Arens R., et al. CD70-driven costimulation induces survival or Fas-mediated apoptosis of T cells depending on antigenic load. J Immunol 2012, 188(May (9)):4256-4267.
82. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001, 15(November (5)):801-812.
83. Badovinac V.P., Haring J.S., Harty J.T. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 2007, 26(June (6)):827-841.
84. Badovinac V.P., Porter B.B., Harty J.T. Programmed contraction of CD8(+) T cells after infection. Nat Immunol 2002, 3(July (7)):619-626.
85. Hamilton S.E., Harty J.T. Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells. J Immunol 2002, 169(November (9)):4936-4944.
86. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001, 2(May (5)):415-422.
87. Kedl R.M., Rees W.A., Hildeman D.A., Schaefer B., Mitchell T., Kappler J., et al. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 2000, 192(October (8)):1105-1114.
88. Defrance T., Casamayor-Palleja M., Krammer P.H. The life and death of a B cell. Adv Cancer Res 2002, 86:195-225.
89. Diener E., Feldmann M. Mechanisms at the cellular level during induction of high zone tolerance in vitro. Cell Immunol 1972, 5(September (1)):130-136.
90. Swinton J., Schweitzer A.N., Anderson R.M. Two signal activation as an explanation of high zone tolerance: a mathematical exploration of the nature of the second signal. J Theor Biol 1994, 169(July (1)):23-30.
91. Lamb J.R., Skidmore B.J., Green N., Chiller J.M., Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983, 157(May (5)):1434-1447.
92. Matis L.A., Glimcher L.H., Paul W.E., Schwartz R.H. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U.S.A. 1983, 80(October (19)):6019-6023.
93. Suzuki G., Kawase Y., Koyasu S., Yahara I., Kobayashi Y., Schwartz R.H. Antigen-induced suppression of the proliferative response of T cell clones. J Immunol 1988, 140(March (5)):1359-1365.
94. Kadowaki N., Ho S., Antonenko S., de Waal Malefyt R., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194(September (6)):863-870.
95. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G. Early programming of T cell populations responding to bacterial infection. J Immunol 2000, 165(December (12)):6833-6839.
96. van Stipdonk M.J., Lemmens E.E., Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2001, 2(May (5)):423-429.
97. Corbin G.A., Harty J.T. Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T cell response to Listeria monocytogenes infection. J Immunol 2004, 173(November (9)):5679-5687.
98. Gerlach C., van Heijst J.W., Schumacher T.N. The descent of memory T cells. Ann N Y Acad Sci 2011, 1217 (January):139-153.
99. van Heijst J.W., Gerlach C., Swart E., Sie D., Nunes-Alves C., Kerkhoven R.M., et al. Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient. Science 2009, 325(September (5945)):1265-1269.
100. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22(March (3)):659-661.
101. Rubner M., Ueber den einfluss der korpergrosse auf stoff- und kraftwechsel. Z Biol 1883, 19:535-562.
102. Curtsinger J., Valenzuela J., Agarwal P., Lins D., Mescher M. Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005, 174:4465-4469.
103. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., Mescher M.F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005, 174(April (8)):4465-4469.
104. Valenzuela J., Schmidt C., Mescher M. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol 2002, 169(December (12)):6842-6849.
105. Araki K., Youngblood B., Ahmed R. The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev 2011, 235(May (1)):234-243.
106. Joshi N.S., Cui W., Chandele A., Lee H.K., Urso D.R., Hagman J., et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007, 27(August (2)):281-295.
107. Glenny A.T. The principles of immunity applied to protective inoculation against diphtheria. J Hyg 1925, 24(December (3-4)):301-320.
108. Glenny A.T. Insoluble precipitates in diphtheria and tetanus immunization. Br Med J 1930, 2(August (3632)):244-245.
109. Glenny A.T., Barr M. The precipitation of diphtheria toxoid by potash alum. J Pathol Bacteriol 1931, 34(2):131-138.
110. Glenny A.T., Sudmersen H.J. Notes on the production of immunity to diphtheria toxin. J Hyg 1921, 20(October (2)):176-220.
111. White R.G., Coons A.H., Connolly J.M. Studies on antibody production III. The alum granuloma. J Exp Med 1955, 102(July (1)):73-82.
112. Holt L.B. Quantitative studies in diphtheria prophylaxis; the primary response. Br J Exp Pathol 1949, 30(August (4)):289-297.
113. Holt L.B. Quantitative studies in diphtheria prophylaxis: the second response. Br J Exp Pathol 1950, 31(April (2)):233-241.
114. Rosenberg S.A., Yang J.C., Kammula U.S., Hughes M.S., Restifo N.P., Schwarz S.L., et al. Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine. J Immunother 2010, 33(July-August (6)):626-629.
115. Rosenberg S.A., Yang J.C., Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004, 10(September (9)):909-915.
116. Speiser D.E., Schwarz K., Baumgaertner P., Manolova V., Devevre E., Sterry W., et al. Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. J Immunother 2010, 33(October (8)):848-858.
117. Assudani D., Cho H.I., DeVito N., Bradley N., Celis E. In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells. Cancer Res 2008, 68(December (23)):9892-9899.
118. Reinhardt R.L., Bullard D.C., Weaver C.T., Jenkins M.K. Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med 2003, 197(March (6)):751-762.
119. Jelley-Gibbs D.M., Brown D.M., Dibble J.P., Haynes L., Eaton S.M., Swain S.L. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med 2005, 202(September (5)):697-706.
120. Kim T.S., Hufford M.M., Sun J., Fu Y.X., Braciale T.J. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med 2010, 207(June (6)):1161-1172.
121. Takamura S., Roberts A.D., Jelley-Gibbs D.M., Wittmer S.T., Kohlmeier J.E., Woodland D.L. The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen. J Exp Med 2010, 207(June (6)):1153-1160.
122. Turner D.L., Cauley L.S., Khanna K.M., Lefrancois L. Persistent antigen presentation after acute vesicular stomatitis virus infection. J Virol 2007, 81(February (4)):2039-2046.
123. Zammit D.J., Turner D.L., Klonowski K.D., Lefrancois L., Cauley L.S. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 2006, 24(April (4)):439-449.
124. Mori I., Komatsu T., Takeuchi K., Nakakuki K., Sudo M., Kimura Y. Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. J Gen Virol 1995, 76(May (Pt 5)):1251-1254.
125. Schwarze J., O'Donnell D.R., Rohwedder A., Openshaw P.J. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004, 169(April (7)):801-805.
126. Kaufmann D.E., Walker B.D. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection. Curr Opin HIV AIDS 2008, 3(May (3)):362-367.
127. Moskophidis D., Lechner F., Pircher H., Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993, 362(April (6422)):758-761.
128. Nolz J.C., Harty J.T. Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection. Immunity 2011, 34(May (5)):781-793.
129. Recher M., Lang K.S., Navarini A., Hunziker L., Lang P.A., Fink K., et al. Extralymphatic virus sanctuaries as a consequence of potent T-cell activation. Nat Med 2007, 13(November (11)):1316-1323.
130. Shin H., Blackburn S.D., Intlekofer A.M., Kao C., Angelosanto J.M., Reiner S.L., et al. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 2009, 31(August (2)):309-320.
131. Shin H., Wherry E.J. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007, 19(August (4)):408-415.
132. Fauci A.S., Morens D.M. The perpetual challenge of infectious diseases. New Engl J Med 2012, 366(February (5)):454-461.
133. Maurice J.M., Davey S. World Health Organization, UNICEF, World Bank, Ebrary Inc. State of the world's vaccines and immunization 2009, World Health Organization, Geneva, xxxiii, 169 p. 3rd ed.
134. Andre F.E. Vaccinology: past achievements, present roadblocks and future promises. Vaccine 2003, 21(January (7-8)):593-595.
135. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. New Engl J Med 2007, 357(November (19)):1903-1915.
136. Amanna I.J., Slifka M.K., Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol Rev 2006, June (211):320-337.
137. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003, 171(November (10)):4969-4973.
138. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003, 9(September (9)):1131-1137.
139. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New Engl J Med 2006, 355(September (10)):1018-1028.
140. Intlekofer A.M., Banerjee A., Takemoto N., Gordon S.M., Dejong C.S., Shin H., et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008, 321(July (5887)):408-411.
141. Parish I.A., Kaech S.M. Diversity in CD8(+) T cell differentiation. Curr Opin Immunol 2009, 21(June (3)):291-297.
142. Sullivan B.M., Juedes A., Szabo S.J., von Herrath M., Glimcher L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U.S.A. 2003, 100(December (26)):15818-15823.
143. Takemoto N., Intlekofer A.M., Northrup J.T., Wherry E.J., Reiner S.L. Cutting edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol 2006, 177(December (11)):7515-7519.
144. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003, 4(March (3)):225-234.
145. Ely K.H., Cookenham T., Roberts A.D., Woodland D.L. Memory T cell populations in the lung airways are maintained by continual recruitment. J Immunol 2006, 176(January (1)):537-543.
146. Hikono H., Kohlmeier J.E., Takamura S., Wittmer S.T., Roberts A.D., Woodland D.L. Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med 2007, 204(July (7)):1625-1636.
147. Belz G.T., Bedoui S., Kupresanin F., Carbone F.R., Heath W.R. Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells. Nat Immunol 2007, 8(October (10)):1060-1066.
148. Gebhardt T., Mueller S.N., Heath W.R., Carbone F.R. Peripheral tissue surveillance and residency by memory T cells. Trends Immunol 2012 October, pii: S1471-4906(12)00146-9. http://dx.doi.org/10.1016/j.it.2012.08.008. [Epub ahead of print].
149. Mackay L.K., Stock A.T., Ma J.Z., Jones C.M., Kent S.J., Mueller S.N., et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U.S.A. 2012, 109(May (18)):7037-7042.
150. Shin H., Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012, (October).
151. Marzo A.L., Klonowski K.D., Le Bon A., Borrow P., Tough D.F., Lefrancois L. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol 2005, 6(August (8)):793-799.
152. Hamann D., Baars P.A., Rep M.H., Hooibrink B., Kerkhof-Garde S.R., Klein M.R., et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997, 186(November (9)):1407-1418.
153. Masopust D., Vezys V., Marzo A.L., Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001, 291(March (5512)):2413-2417.
154. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401(October (6754)):708-712.
155. Marzo A.L., Yagita H., Lefrancois L. Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J Immunol 2007, 179(July (1)):36-40.
156. Pepper M., Jenkins M.K. Origins of CD4(+) effector and central memory T cells. Nat Immunol 2011, 12(June (6)):467-471.
157. Pepper M., Linehan J.L., Pagan A.J., Zell T., Dileepan T., Cleary P.P., et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 2010, 11(January (1)):83-89.
158. Pepper M., Pagan A.J., Igyarto B.Z., Taylor J.J., Jenkins M.K. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 2011, 35(October (4)):583-595.
159. Garcia-Hernandez Mde L., Hamada H., Reome J.B., Misra S.K., Tighe M.P., Dutton R.W. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. J Immunol 2012, 184(April (8)):4215-4227.
160. Hinrichs C.S., Kaiser A., Paulos C.M., Cassard L., Sanchez-Perez L., Heemskerk B., et al. Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 2009, 114(July (3)):596-599.
161. Reiner S.L., Sallusto F., Lanzavecchia A. Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. Science 2007, 317(August (5838)):622-625.
162. Baitsch L., Baumgaertner P., Devevre E., Raghav S.K., Legat A., Barba L., et al. Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients. J Clin Invest 2011, 121(June (6)):2350-2360.
163. Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis 2007, 27(May (2)):152-160.
164. Wherry E.J. T cell exhaustion. Nat Immunol 2011, 12(June (6)):492-499.
165. Youngblood B., Wherry E.J., Ahmed R. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr Opin HIV AIDS 2012, 7(January (1)):50-57.
166. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008, 28(May (5)):710-722.
167. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10(January (1)):116-125.
168. Welters M.J., Kenter G.G., de Vos van Steenwijk P.J., Lowik M.J., Berends-van der Meer D.M., Essahsah F., et al. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc Natl Acad Sci U.S.A. 2010, 107(June (26)):11895-11899.
169. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13(July (7)):843-850.
170. Thakur A., Pedersen L.E., Jungersen G. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012, 30(July (33)):4907-4920.